GDF15 and metabolic dysfunction-associated steatotic liver disease: Given that very little is known regarding the potential regulatory factors of elevated GDF-15 in patients with NAFLD and T2DM, we next looked to identify the factors associated with T2DM that were independently associated with GDF-15 concentrations.